CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages
about
In vitro correlates of HIV-2-mediated HIV-1 protectionTransmission of human hepatitis C virus from patients in secondary cells for long term cultureHIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin familyDeterminants of HIV-1 coreceptor function on CC chemokine receptor 3. Importance of both extracellular and transmembrane/cytoplasmic regionsGenomic organization and promoter characterization of human CXCR4 genePotent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140Peptide and protein-based inhibitors of HIV-1 co-receptorsCD8(+) T-cell effector function and transcriptional regulation during HIV pathogenesisNovel function of prothymosin alpha as a potent inhibitor of human immunodeficiency virus type 1 gene expression in primary macrophagesResistance against syncytium-inducing human immunodeficiency virus type 1 (HIV-1) in selected CD4(+) T cells from an HIV-1-infected nonprogressor: evidence of a novel pathway of resistance mediated by a soluble factor(s) that acts after virus entryAlpha-defensins inhibit HIV infection of macrophages through upregulation of CC-chemokines.Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.Patterns of CCR5, CXCR4, and CCR3 usage by envelope glycoproteins from human immunodeficiency virus type 1 primary isolates.Differentiation of promonocytic U937 subclones into macrophagelike phenotypes regulates a cellular factor(s) which modulates fusion/entry of macrophagetropic human immunodeficiency virus type 1.Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1Anti-feline immunodeficiency virus (FIV) soluble factor(s) produced from antigen-stimulated feline CD8(+) T lymphocytes suppresses FIV replication.Human immunodeficiency virus (HIV)-positive sera obtained shortly after seroconversion neutralize autologous HIV type 1 isolates on primary macrophages but not on lymphocytes.Cathepsin G, a neutrophil-derived serine protease, increases susceptibility of macrophages to acute human immunodeficiency virus type 1 infectionDifferential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production.Reciprocal interactions between human T-lymphotropic virus type 1 and prostaglandins: implications for viral transmission.Bone marrow CD34(+) cells and megakaryoblasts secrete beta-chemokines that block infection of hematopoietic cells by M-tropic R5 HIV.Prothymosin-alpha inhibits HIV-1 via Toll-like receptor 4-mediated type I interferon induction.CCL3 genotype and current depression increase risk of HIV-associated dementiaHigh beta-chemokine expression levels in lymphoid tissues of simian/human immunodeficiency virus 89.6-vaccinated rhesus macaques are associated with uncontrolled replication of simian immunodeficiency virus challenge inoculum.A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activationIn vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibitionCD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression.Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27.Control of HIV-1 infection by soluble factors of the immune response.Primary CD8+ cells from HIV-infected individuals can suppress productive infection of macrophages independent of beta-chemokinesCCR5 susceptibility to ligand-mediated down-modulation differs between human T lymphocytes and myeloid cells.CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokinesFactors secreted by human T lymphotropic virus type I (HTLV-I)-infected cells can enhance or inhibit replication of HIV-1 in HTLV-I-uninfected cells: implications for in vivo coinfection with HTLV-I and HIV-1Promonocytic U937 subclones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion by T-cell-tropic human immunodeficiency virus type 1.The CXC chemokine stromal cell-derived factor 1 is not responsible for CD8+ T cell suppression of syncytia-inducing strains of HIV-1.Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.Induction of a Soluble Anti-HIV-1 factor (s) with IFN-γ, IL-10, and β-Chemokine Modulating Activity by an Influenza-Bacterial Polyantigenic Mixture.Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1.Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.
P2860
Q22254217-5E7AAB20-2DC3-451E-A15E-1F99BBEEE19CQ24800686-395D7DCC-11C5-456A-8913-0DF9795CC47EQ28214202-E68F733C-6477-4426-BB89-4D00A6596E1DQ28245934-210DA14A-A7EB-4B88-98B8-59486EDE13A8Q28271622-77F05C8A-5C28-41C1-BE0F-CF471B60C6FBQ28345395-5B42B61B-7867-4D10-8F46-B2CD7D5C2D4EQ30352117-2B043A0A-4632-4F8E-BD27-AC7506EF5C11Q30432007-83FE94FA-5A61-4D52-9F65-089248F5D52EQ30445480-CD15398F-2AA3-4656-97B1-D0442805177FQ33650739-88465A12-D325-4656-B975-411F5F358468Q33669536-A0812193-648E-4283-BD46-A0BE5B204EC8Q33782007-445A9F92-BF0D-4BBC-A359-4CAAA6C64CD8Q33782930-2E48628C-B4B8-4D4E-97EB-FC04FC8E8762Q33783481-510462EF-49D7-4D09-9E2B-8ABEC88BD2E5Q33784182-8D1AB74C-AF15-43F4-BA7A-AF8EAA029066Q33796047-588D428D-BEE7-42F5-A054-3AC6BC3F9F84Q33805324-61EEADFC-85D2-4650-8EC1-5C531BE8D45AQ33808640-0FE30A5A-3434-4BBA-8C8D-6D638D29ADA4Q33827798-751CCA73-FD1C-425F-B656-69C1B72CA026Q33834689-40C2987E-ACE5-4461-94CB-68185807026BQ33903275-D742086E-25F6-4CAF-A3D1-EB47FE681B53Q33933182-D40AF28F-732E-4576-A68F-C6A1D3297AA6Q34072394-2DC372EE-F827-42AB-9FEE-54BCA0311E62Q34192490-099A50BB-DCD7-4E53-9680-809612D1179FQ34356962-A590BE3E-74D9-4233-9551-60FFB060E5BEQ34445208-F1E42590-3AF8-49AF-B7D1-F9672B5A6E9EQ35020718-5005E580-A20F-4702-9035-BDA6A05F11C3Q35114369-00E51911-9F63-45EB-ACF1-B02072A010F7Q35642774-E271B071-A996-4EDE-B5EF-1C9926BA6476Q35752416-9E1E6DA2-2400-4442-89F8-B37D583A4D36Q35886502-320AAF38-43D9-4DF8-B97C-1FD0F1CF654FQ36028163-8CDD434C-5FD6-4582-A794-89801C3A7999Q36065955-AB6CFA55-8455-4198-A070-0F9192FFAA24Q36400897-CFF38F2D-A691-474F-AC54-657B5736F944Q36549131-82D7B824-F8C2-44B2-AE26-2AF97B03B56DQ36576683-5BB54971-3C29-4548-ACE0-404A0CBF5428Q37372729-FE48EBB2-96DE-466E-A8A3-49AF19249091Q37375957-D2E7D0BB-8BCF-4AC9-B598-A736EE404690Q37385745-BE286B64-E19A-4F30-906D-1CD26EA71E83Q37387255-464D8415-193E-4EBC-90B7-7E82DC7E183B
P2860
CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CD8+ T-cell-derived soluble fa ...... cation in monocyte/macrophages
@en
CD8+ T-cell-derived soluble fa ...... ation in monocyte/macrophages.
@nl
type
label
CD8+ T-cell-derived soluble fa ...... cation in monocyte/macrophages
@en
CD8+ T-cell-derived soluble fa ...... ation in monocyte/macrophages.
@nl
prefLabel
CD8+ T-cell-derived soluble fa ...... cation in monocyte/macrophages
@en
CD8+ T-cell-derived soluble fa ...... ation in monocyte/macrophages.
@nl
P2093
P2860
P356
P1476
CD8+ T-cell-derived soluble fa ...... cation in monocyte/macrophages
@en
P2093
Combadiere C
Moriuchi H
Moriuchi M
P2860
P304
15341-15345
P356
10.1073/PNAS.93.26.15341
P407
P577
1996-12-01T00:00:00Z